Dr. Klaus Gottlieb joins Synthetic Biologics leadership team

Klaus Gottlieb, MD, FACG, has joined Synthetic Biologics as its vice president of clinical and regulatory affairs.

Prior to joining Synthetic Biologics, Dr. Gottlieb was the senior medical director of therapeutic strategy – gastroenterology at Fortune 500 company Quintiles, according to the report.

Dr. Gottlieb will provide further leadership support as Synthetic Biologics moves forward with Phase 2 clinical trials for its irritable bowel syndrome and Clostridium difficile products.

He will report directly to Joseph Sliman, MD, MPH, senior vice president of clinical and regulatory affairs.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast